title: Integrin alphavbeta3-RGDS interaction mediates fibrin-induced morphological changes of glomerular endothelial cells.
abstract: BACKGROUND
  In our previous studies, we found that intraglomerular deposition of fibrin and its metabolites was related to glomerular sclerosis and reduced renal function. It has been reported that both overlying and underlying fibrin may induce specific morphological changes of cultured endothelial cells from large blood vessels. The dependency of these morphological changes on the integrin alphavbeta3-arginyl-glycyl-aspartyl-serine (RGDS) interaction is still controversial. We hypothesized that glomerular endothelial cells (GECs) stimulated by fibrin might undergo morphological changes through an integrin alphavbeta3-RGDS interaction. Methods. In vitro studies were performed to examine the growing status of GECs stimulated by overlying and underlying fibrin gels in the presence or absence of the following: 50 microg/ml anti-alphavbeta3 integrin monoclonal antibody 23C6 or nonimmune mouse IgG, 1 mg/ml synthetic RGDS or arginyl-glycyl-glycyl-serine (RGGS) peptide, 10 mg/ml sodium heparin, 100 microg/ml cycloheximide, and 10 microM actinomycin D. Fast protein liquid chromatography (FPLC)-purified fibrinogen and the third to fifth passages of human GECs were also used in this study.
  
  
  RESULTS
  GECs developed capillary tube structure after 60 hours of culturing on fibrin gels, and GECs cultured on gelatin-coated plates displayed a monolayer of cobblestone-like cells in the presence or absence of 23C6 and synthetic RGDS peptide. Fibrin-induced capillary tube formation was promoted by 23C6 and inhibited by RGDS peptide, cycloheximide, and actinomycin D. Disorganization of the GEC monolayer was induced by overlying fibrin, but was not induced by overlying agarose gels and glass cover slips or culturing in fibrinogen, 0.05 NIH U/ml thrombin, fibrin supernatants, as well as in fibrin degradation products. Disorganization of GEC monolayer can be induced by both des-AA-fibrin and des-AABB-fibrin and was unaffected by heparin. Furthermore, both 23C6 and synthetic RGDS peptide prevented disorganization of GECs induced by overlying fibrin, whereas nonimmune mouse IgG, synthetic RGGS peptide, cycloheximide, and actinomycin D had no similar effect.
  
  
  CONCLUSIONS
  GECs cultured on fibrin gels may develop capillary structure spontaneously, and GECs covered by fibrin gels may undergo disorganization. Our data suggest that these GEC morphological changes are mediated by an integrin alphavbeta3-RGDS interaction.
authors.affiliation: Department of Nephrology, Kidney Center of Chinese PLA, PLA Key Laboratry of Nephrology, General Hospital of Chinese PLA, PLA Postgraduate Medical School, Beijing, People's Republic of China.
authors.forename: Q
authors.initials: Q
authors.lastname: Xu
authors.forename: X
authors.initials: X
authors.lastname: Chen
authors.forename: B
authors.initials: B
authors.lastname: Fu
authors.forename: Y
authors.initials: Y
authors.lastname: Ye
authors.forename: L
authors.initials: L
authors.lastname: Yu
authors.forename: J
authors.initials: J
authors.lastname: Wang
authors.forename: W
authors.initials: W
authors.lastname: Li
authors.forename: Q
authors.initials: Q
authors.lastname: Cheng
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology; D002450:Cell Communication / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004727:Endothelium / Q000166:cytology / Q000187:drug effects; D005337:Fibrin / Q000494:pharmacology*; D005340:Fibrinogen / Q000302:isolation & purification / Q000494:pharmacology; D005780:Gelatin / Q000494:pharmacology; D005782:Gels; D005923:Glomerulosclerosis, Focal Segmental / Q000378:metabolism; D006801:Humans; D007678:Kidney Glomerulus / Q000166:cytology*; D009842:Oligopeptides / Q000378:metabolism*; D010975:Platelet Aggregation Inhibitors / Q000378:metabolism*; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D019030:Receptors, Vitronectin / Q000276:immunology / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D005782:Gels; D009842:Oligopeptides; D010975:Platelet Aggregation Inhibitors; D011500:Protein Synthesis Inhibitors; D019030:Receptors, Vitronectin; D003609:Dactinomycin; D005780:Gelatin; D005337:Fibrin; D005340:Fibrinogen; D003513:Cycloheximide; C046617:arginyl-glycyl-aspartyl-serine